MYC and triple-negative breast carcinoma: [7,8,9] We have previously demonstrated that MYC regulates the transcription of several polyamine metabolizing enzymes (PMEs) in triple negative breast cancer and that a plasma polyamine signature is associated with TNBC development and progression.